Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by 4Moving Biotech
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis
July 16, 2025
From
4Moving Biotech
Via
Business Wire
Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis
March 27, 2025
From
4Moving Biotech
Via
Business Wire
4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth
July 02, 2024
From
4Moving Biotech
Via
Business Wire
4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients
June 10, 2024
From
4Moving Biotech
Via
Business Wire
4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts
November 10, 2023
From
4Moving Biotech
Via
Business Wire
4Moving Biotech Completes the Recruitment of Its Phase I Clinical Trial in Patients With Knee Osteoarthritis
October 19, 2023
From
4Moving Biotech
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.